Approval · Notice of Compliance 18288 · 2016
NORVIR: Notice of Compliance 18288
Issued July 12, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18288
- Date
- July 12, 2016
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to safety information regarding llipodystrophy and addition of monitoring of blood glucose related to risk of hyperglycemia/new onset diabete mellitus
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORVIR | Not yet assigned | — |